BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


Instant NanoBiosensors Co., Ltd. - TAcc+


Instant NanoBiosensors Co., Ltd. - TAcc+

Company Info

Name /Instant NanoBiosensors Co., Ltd. - TAcc+

Address /2F., No. 459, Chongyang Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)

Website /

Expecting startup year /

No. of team members /


Name /Tony Chung

Title /CEO

Email /

Telephone /(Work) 02-2653-8655

Fax /

Mobile /0961-094-113

Company Type


About the Company

In 2020, we are one of top 12 innovative young companies for worldwide strategic collaboration selected by Merck KGaA. Our technology can shorten the time consumed in detecting biomarker at the laboratory from three hours to just several minutes and enhance the detection sensitivity of devices which allows our product to gather data comparable to top diagnostic laboratories. Monitoring disease progression after drug treatment can also be done more effectively by combining novel biomarkers with a cutting-edge biosensing platform to assist the patients in achieving the goal of self-health management. especially for patients with cancers, neurodegenerative diseases or infectious diseases.

Brief Description of main products or services

Key Products

Our key products are based on the unique & patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance). FOPPR has proved to be a promising technology with high analytical sensitivity (1,000-fold higher than conventional ELISA) with preferrable specificity. Our instrument Light-Sensing Biomarker Analyzer (platform) offers instant and accurate results for a variety of applications. The additional beneficial features provided are portable ease of use, inexpensive sensor chips, remote mode connected to telehealth for digital health management.

Market issues

Researchers and clinicians rely extensively on biomarkers as research and clinical tools. However, many biomarkers are not detectable using conventional technologies. Under this circumstance, biomarkers only detected with relatively narrow ranges that reflect more advanced disease conditions. For advanced medical research and early disease diagnosis, the biomarker detection range need to expand into wide range.

Our Solutions

The label-free and bio interaction-based detection of FOPPR™ enables a wide range of applications in biochemical research, development and diagnostic processes.

Contact Person

Name /Suri Huang

Email /

Phone /0912619006